COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥11,045,832 | CN¥10,374,576 | CN¥10,058,504 | CN¥10,324,911 |
| - Cash | CN¥2,517,886 | CN¥2,388,158 | CN¥1,796,653 | CN¥1,909,371 |
| + Debt | CN¥4,175,674 | CN¥4,430,242 | CN¥4,973,551 | CN¥4,341,965 |
| Enterprise Value | CN¥12,703,620 | CN¥12,416,659 | CN¥13,235,403 | CN¥12,757,506 |
| Revenue | CN¥4,449,361 | CN¥4,426,826 | CN¥4,385,441 | CN¥4,929,415 |
| % Growth | 0.5% | 0.9% | -11% | – |
| Gross Profit | CN¥318,041 | CN¥300,239 | CN¥354,213 | CN¥20,186 |
| % Margin | 7.1% | 6.8% | 8.1% | 0.4% |
| EBITDA | CN¥11,149 | CN¥165,161 | CN¥229,623 | -CN¥167,787 |
| % Margin | 0.3% | 3.7% | 5.2% | -3.4% |
| Net Income | -CN¥28,061 | CN¥66,715 | CN¥40,532 | CN¥15,525 |
| % Margin | -0.6% | 1.5% | 0.9% | 0.3% |
| EPS Diluted | -0.015 | 0.036 | 0.022 | 0.008 |
| % Growth | -142.1% | 64.7% | 159.5% | – |
| Operating Cash Flow | CN¥421,644 | CN¥1,048,103 | -CN¥256,367 | CN¥0 |
| Capital Expenditures | -CN¥202,671 | -CN¥126,047 | -CN¥123,906 | -CN¥171,453 |
| Free Cash Flow | CN¥218,973 | CN¥922,056 | -CN¥380,273 | -CN¥115,200 |